ImpediMed opens States-side
Wednesday, 18 June, 2008
Queensland Premier Anna Bligh opened Brisbane-based medical company ImpediMed's (ASX: IPD) US headquarters at BIO 2008 yesterday.
The new San Diego headquarters will take over the most of the manufacturing, customer training and technical service duties of the company.
However, the office in Brisbane will remain ImpediMed's head office, and will continue to be responsible for the financial and corporate development roles, as well as the company's clinical trials and research.
ImpediMed develops and sells medical devices, including a tool used to detect and assess lymphoedema, a disease commonly suffered by cancer patients, particularly those with breast cancer.
Cartherics and Catalent announce enhanced partnership
To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...
Alliance seeks to boost regional capacity in clinical trials
Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...
Lipid science receives new Australia-led online hub
The Lipid Network launched this month to build links between researchers, clinicians and industry...
